IgG from Patients with Lambert-Eaton Syndrome Blocks Voltage-Dependent Calcium Channels
- 22 January 1988
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 239 (4838) , 405-408
- https://doi.org/10.1126/science.2447652
Abstract
Lambert-Eaton syndrome, an autoimmune disorder frequently associated with small-cell carcinoma of the lung, is characterized by impaired evoked release of acetylcholine from the motor nerve terminal. Immunoglobulin G (IgG) antibodies from patients with the syndrome, applied to bovine adrenal chromaffin cells, reduced the voltage-dependent calcium channel currents by about 40 percent. When calcium was administered directly into the cytoplasm, however, the IgG-treated cells exhibited normal exocytotic secretion, as assayed by membrane capacitance measurement. Measurement with the fluorescent calcium indicator fura-2 indicated that the IgG treatment reduced potassium-stimulated increase in free intracellular calcium concentration. The pathogenic IgG modified neither kinetics of calcium channel activation nor elementary channel activity, suggesting that a reduction in the number of functional calcium channels underlies the IgG-induced effect. Therefore, Lambert-Eaton syndrome IgG reacts with voltage-dependent calcium channels and blocks their function, a phenomenon that can account for the presynaptic impairment characteristic of this disorder.This publication has 35 references indexed in Scilit:
- Immunoglobulins of Lambert‐Eaton myasthenic syndrome inhibit rat pituitary hormone releaseAnnals of Neurology, 1987
- Lambert‐Eaton Myasthenic Syndrome: Evidence for Calcium Channel BlockadeaAnnals of the New York Academy of Sciences, 1987
- Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cellsNature, 1986
- Passively transferred lambert‐eaton syndrome in mice receiving purified IgGMuscle & Nerve, 1986
- Autonomic dysfunction and Eaton Lambert syndromeJournal of the Autonomic Nervous System, 1985
- Passive transfer of the Lambert‐Eaton myasthenic syndrome: Neuromuscular transmission in mice injected with plasmaMuscle & Nerve, 1985
- Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channelsNature, 1984
- Paucity and disorganization of presynaptic membrane active zones in the lambert‐eaton myasthenic syndromeMuscle & Nerve, 1982
- Eaton‐lambert myasthenic syndrome: Long‐term treatment of three patients with prednisoneAnnals of Neurology, 1981
- Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine.Journal of Neurology, Neurosurgery & Psychiatry, 1980